A subset of metastatic brain tumors occurs in deep-seated locations. Accessing and resecting these lesions can be associated with significant morbidity because it involves large craniotomies, extensive white matter dissection, prolonged retraction, and risk of inadvertent tissue injury. As a result, only palliative treatment options are typically offered for these lesions including observation, needle biopsies, and/or radiation therapy. With the development of new surgical tools and techniques, minimally invasive techniques have allowed for the treatment of these lesions previously associated with significant morbidity. These minimally invasive techniques include laser interstitial thermal therapy and channel-based resections
The clinical management/understanding of brain metastases (BM) has changed substantially in the last...
Abstract Brain metastases are significant causes of morbidity or mortality for patients with metasta...
Recent therapeutic advances involving the use of systemic targeted treatments and immunotherapeutic ...
Treatment approaches for metastatic brain tumors continue to evolve, with increasing recent emphasis...
Breast cancer is the most common malignancy among women worldwide, and the main cause of death in pa...
Brain metastases remain the most common neurologic complication of cancer. With improvement in surve...
Journal ArticleThe primary goal in removing a metastatic brain tumor is to maximize surgical resecti...
Brain metastasis (BM), classified as a secondary brain tumor, is the most common malignant central n...
Metastatic tumours are the most common form of cerebral neoplasm, occurring in up to 40% of patients...
New Perspectives on Brain Metastasis Out of the Darkroom Equity and Health House Call: Blood and Pla...
Importance Brain metastasis (BM) is the most common malignant intracranial neoplasm in adults with ...
The treatment of brain tumors has evolved over the past few decades. While whole brain radiation the...
Metastatic tumours are the most common form of cerebral neoplasm, occurring in up to 40% of patients...
The Jefferson Center for Minimally Invasive Cranial Base Surgery and Endoscopic Neurosurgery reflect...
Abstract Brain metastases remain the commonest type of brain tumour, being four times more common th...
The clinical management/understanding of brain metastases (BM) has changed substantially in the last...
Abstract Brain metastases are significant causes of morbidity or mortality for patients with metasta...
Recent therapeutic advances involving the use of systemic targeted treatments and immunotherapeutic ...
Treatment approaches for metastatic brain tumors continue to evolve, with increasing recent emphasis...
Breast cancer is the most common malignancy among women worldwide, and the main cause of death in pa...
Brain metastases remain the most common neurologic complication of cancer. With improvement in surve...
Journal ArticleThe primary goal in removing a metastatic brain tumor is to maximize surgical resecti...
Brain metastasis (BM), classified as a secondary brain tumor, is the most common malignant central n...
Metastatic tumours are the most common form of cerebral neoplasm, occurring in up to 40% of patients...
New Perspectives on Brain Metastasis Out of the Darkroom Equity and Health House Call: Blood and Pla...
Importance Brain metastasis (BM) is the most common malignant intracranial neoplasm in adults with ...
The treatment of brain tumors has evolved over the past few decades. While whole brain radiation the...
Metastatic tumours are the most common form of cerebral neoplasm, occurring in up to 40% of patients...
The Jefferson Center for Minimally Invasive Cranial Base Surgery and Endoscopic Neurosurgery reflect...
Abstract Brain metastases remain the commonest type of brain tumour, being four times more common th...
The clinical management/understanding of brain metastases (BM) has changed substantially in the last...
Abstract Brain metastases are significant causes of morbidity or mortality for patients with metasta...
Recent therapeutic advances involving the use of systemic targeted treatments and immunotherapeutic ...